Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 59Squamous Cell Carcinoma of Head and Neck 55Head and Neck Neoplasms 55Prostatic Neoplasms 40Oropharyngeal Neoplasms 24Carcinoma, Non-Small-Cell Lung 23Carcinoma, Squamous Cell 21Rectal Neoplasms 19Breast Neoplasms 19Nasopharyngeal Neoplasms 14Neoplasm Metastasis 13Glioblastoma 13Carcinoma 13Esophageal Neoplasms 12Uterine Cervical Neoplasms 11Pancreatic Neoplasms 11Lung Neoplasms 11Glioma 11Esophageal Squamous Cell Carcinoma 11Sarcoma 9Radiation Injuries 8Neoplasms 8Laryngeal Neoplasms 8Brain Neoplasms 8Urinary Bladder Neoplasms 7Tongue Neoplasms 7Mouth Neoplasms 7Hypopharyngeal Neoplasms 7Carcinoma, Hepatocellular 6Astrocytoma 6

Interventions

Oxaliplatin 32Fluorouracil 24Gemcitabine 23Leucovorin 19Docetaxel 19pembrolizumab 17Capecitabine 15Radiotherapy 14Irinotecan 13Cisplatin 11Bevacizumab 11Nivolumab 8130-nm albumin-bound paclitaxel 8Trastuzumab 7Erlotinib Hydrochloride 7Cyclophosphamide 7Albumin-Bound Paclitaxel 7Radiosurgery 6Paclitaxel 6Taxes 5S 1 (combination) 5Metformin 5Carboplatin 5Blood Specimen Collection 5Sunitinib 4Sorafenib 4Pemetrexed 4Esophagectomy 4Chemoradiotherapy 4Cetuximab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma × Radiotherapy, Intensity-Modulated × Clear all
NCT01512589 2026-04-15

Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
147 enrolled
Gastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT03536182 2021-05-26

CIPHER

University of Texas Southwestern Medical Center

Phase 3 Withdrawn
Tumor-Agnostic

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡